Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page
- Check3 days agoChange DetectedRecruitment status is updated to indicate no new enrollments for this study. The update also adds a few navigation/label changes and a revision note (v3.6.0), including new sections like 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' while standardizing the 'Intervention/Treatment' heading.SummaryDifference0.4%

- Check11 days agoChange DetectedThe page shows a new revision label, v3.5.5, replacing the prior v3.5.4. This indicates a different published version of the page, likely an administrative update rather than a substantive change to study details.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer now shows revision v3.5.4 instead of v3.5.3. This signals an update to the site's documentation version rather than any study details.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study record revision was incremented from v3.5.2 to v3.5.3, replacing the previous revision. This indicates a minor update to the record or its documents.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.